Kuate Defo Barthelemy, Mbanya Jean Claude, Tardif Jean-Claude, Ekundayo Olugbemiga, Perreault Sylvie, Potvin Louise, Cote Robert, Kengne Andre Pascal, Choukem Simeon Pierre, Assah Felix, Kingue Samuel, Richard Lucie, Pongou Roland, Frohlich Katherine, Saji Jude, Fournier Pierre, Sobngwi Eugene, Ridde Valery, Dubé Marie-Pierre, De Denus Simon, Mbacham Wilfred, Lafrance Jean-Philippe, Nsagha Dickson Shey, Mampuya Warner, Dzudie Anastase, Cloutier Lyne, Zarowsky Christina, Tanya Agatha, Ndom Paul, Hatem Marie, Rey Evelyne, Roy Louise, Borgès Da Silva Roxane, Dagenais Christian, Todem David, Weladji Robert, Mbanya Dora, Emami Elham, Njoumemi Zakariaou, Monnais Laurence, Dubois Carl-Ardy
Department of Social and Preventive Medicine, Department of Demography and Public Health Research Institute, Université de Montréal, Montreal, QC, Canada.
Department of Internal Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
JMIR Res Protoc. 2017 May 29;6(5):e102. doi: 10.2196/resprot.7807.
Hypertension holds a unique place in population health and health care because it is the leading cause of cardiovascular disease and the most common noncommunicable condition seen in primary care worldwide. Without effective prevention and control, raised blood pressure significantly increases the risk of stroke, myocardial infarction, chronic kidney disease, heart failure, dementia, renal failure, and blindness. There is an urgent need for stakeholders-including individuals and families-across the health system, researchers, and decision makers to work collaboratively for improving prevention, screening and detection, diagnosis and evaluation, awareness, treatment and medication adherence, management, and control for people with or at high risk for hypertension. Meeting this need will help reduce the burden of hypertension-related disease, prevent complications, and reduce the need for hospitalization, costly interventions, and premature deaths.
This review aims to synthesize evidence on the epidemiological landscape and control of hypertension in Cameroon, and to identify elements that could potentially inform interventions to combat hypertension in this setting and elsewhere in sub-Saharan Africa.
The full search process will involve several steps, including selecting relevant databases, keywords, and Medical Subject Headings (MeSH); searching for relevant studies from the selected databases; searching OpenGrey and the Grey Literature Report for gray literature; hand searching in Google Scholar; and soliciting missed publications (if any) from relevant authors. We will select qualitative, quantitative, or mixed-methods studies with data on the epidemiology and control of hypertension in Cameroon. We will include published literature in French or English from electronic databases up to December 31, 2016, and involving adults aged 18 years or older. Both facility and population-based studies on hypertension will be included. Two reviewers of the team will independently search, screen, extract data, and assess the quality of selected studies using suitable tools. Selected studies will be analyzed by narrative synthesis, meta-analysis, or both, depending on the nature of the data retrieved in line with the review objectives.
This review is part of an ongoing research program on disease prevention and control in the context of the dual burden of communicable and noncommunicable diseases in Africa. The first results are expected in 2017.
This review will provide a comprehensive assessment of the burden of hypertension and control measures that have been designed and implemented in Cameroon. Findings will form the knowledge base relevant to stakeholders across the health system and researchers who are involved in hypertension prevention and control in the community and clinic settings in Cameroon, as a yardstick for similar African countries.
PROSPERO registration number: CRD42017054950; http://www.crd.york.ac.uk/PROSPERO/ display_record.asp?ID=CRD42017054950 (Archived by WebCite at http://www.webcitation.org/6qYSjt9Jc).
高血压在人群健康和医疗保健中占据独特地位,因为它是心血管疾病的首要病因,也是全球初级保健中最常见的非传染性疾病。若没有有效的预防和控制措施,血压升高会显著增加中风、心肌梗死、慢性肾病、心力衰竭、痴呆、肾衰竭及失明的风险。卫生系统中的利益相关者(包括个人和家庭)、研究人员及决策者迫切需要协同合作,以改善高血压患者或高危人群的预防、筛查与检测、诊断与评估、知晓情况、治疗及药物依从性、管理和控制。满足这一需求将有助于减轻高血压相关疾病的负担,预防并发症,并减少住院需求、昂贵的干预措施及过早死亡。
本综述旨在综合喀麦隆高血压的流行病学概况及控制方面的证据,并确定可能为在该国及撒哈拉以南非洲其他地区抗击高血压的干预措施提供依据的因素。
完整的检索过程将包括多个步骤,包括选择相关数据库、关键词和医学主题词(MeSH);从选定数据库中检索相关研究;在OpenGrey和灰色文献报告中检索灰色文献;在谷歌学术中手动检索;以及向相关作者索要遗漏的出版物(如有)。我们将选择有关喀麦隆高血压流行病学及控制数据的定性、定量或混合方法研究。我们将纳入截至2016年12月31日来自电子数据库的法语或英语已发表文献,并涉及18岁及以上成年人。将包括基于机构和人群的高血压研究。团队的两名评审员将独立检索、筛选、提取数据,并使用合适的工具评估选定研究的质量。根据检索到的数据性质及综述目标,选定的研究将通过叙述性综合分析、荟萃分析或两者结合的方式进行分析。
本综述是非洲传染病和非传染病双重负担背景下正在进行的疾病预防与控制研究项目的一部分。预计2017年得出初步结果。
本综述将全面评估喀麦隆高血压的负担以及已设计和实施的控制措施。研究结果将形成与喀麦隆卫生系统各利益相关者以及参与社区和诊所环境中高血压预防与控制的研究人员相关的知识库,作为类似非洲国家的衡量标准。
PROSPERO注册号:CRD42017054950;http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017054950(由WebCite存档于http://www.webcitation.org/6qYSjt9Jc)